Friday, June 20, 2025

 

Low social support and a tendency to compare yourself to others may be associated with problematic social media use, per study of 403 Italian adolescents





PLOS
Social support and social comparison tendencies predict trajectories of adolescents’ problematic social media use: A longitudinal study 

image: 

Low social support and a tendency to compare yourself to others may be associated with problematic social media use, per study of 403 Italian adolescents.

view more 

Credit: cyndidyoder83, Pixabay, CC0 (https://creativecommons.org/publicdomain/zero/1.0/)




Low social support and a tendency to compare yourself to others may be associated with problematic social media use, per study of 403 Italian adolescents

Article URLhttps://plos.io/4kMA1J8

Article title: Social support and social comparison tendencies predict trajectories of adolescents’ problematic social media use: A longitudinal study

Author countries: Italy, Germany

Funding: The author(s) received no specific funding for this work.

 

New research proposes framework to define and measure the biology of health



Columbia University's Mailman School of Public Health





A new paper from Columbia University Mailman School of Public Health, Butler Columbia Aging Center, and Columbia Irving Medical Center introduces a scientific framework for understanding the biological foundation of health—what the researchers term Intrinsic Health. Published in Science Advances, the study lays the groundwork for measuring and promoting health itself, rather than merely treating disease.

Titled “Intrinsic Health as a Foundation for a Science of Health,” the paper defines intrinsic health as a field-like state that supports the body’s ability to maintain internal balance across dynamic biological networks—enabling resilience, performance, and sustainability over time. The authors argue that while medicine has long focused on disease, a robust science of health has remained elusive—until now.

“Understanding the mechanisms that support health—and shifting our focus from late-stage disease treatment to health optimization—was our core objective,” said lead author Alan Cohen, PhD, associate professor of Environmental Health Sciences at the Mailman School and a member of the Butler Columbia Aging Center. “By defining, measuring, and targeting intrinsic health, we move closer to realizing the ultimate aim of health science: helping individuals and populations thrive across the lifespan.”

According to the researchers, intrinsic health arises from the interaction of three essential biological components:

  • Energy: The fundamental requirement for life, supporting the function of cells and organs.
  • Communication: The system’s ability to acquire and transmit information, enabling adaptation and coordination.
  • Structure: The physical framework in which energy and communication support biological function and adaptation.

These components, shaped by billions of years of natural selection, collectively produce health as an emergent, measurable property. Intrinsic health, the researchers note, is quantifiable and tends to decline with age—making it a vital focus for aging research and preventive medicine.

“This is part of a broader scientific and cultural revolution,” said co-author Martin Picard, PhD, associate professor in the Butler Aging Center and Departments of Psychiatry and Neurology at Columbia Irving Medical Center. “We’re moving away from viewing the body as a molecular machine and toward an understanding of the body as an energetic process—life itself, and our health, as fundamentally energetic processes.”

The authors emphasize that the ability to measure intrinsic health could catalyze transformative advances:

  • Test lifestyle and technological interventions for direct impact on health
  • Enable individuals to track and optimize their own health
  • Shift medicine from reactive treatment to proactive health maintenance

“Measuring health itself will allow public health and medicine to focus on building, maintaining, and restoring health—not just preventing and treating disease,” said Cohen.

“With a clear biological target, public health and health care can become increasingly proactive and preventive,” noted senior author Linda P. Fried, MD, MPH, Dean of the Mailman School and Director of the Butler Columbia Aging Center. “This new framework could guide population health improvements, inform policy, and establish metrics to track effectiveness scientifically and systematically.”

Co-authors are John Beard, Dan W. Belsky, Columbia Mailman School and Butler Aging Center;  Julie Herbstman, Christine Kuryla, Molei Liu, Nour Makarem, Daniel Malinsky, Sen Pei, and Ying Wei, Columbia Mailman School.

The Robert N. Butler Columbia Aging Center
Bringing together the campus-wide resources of a top-tier research university, the Robert N. Butler Columbia Aging Center approach to aging science is an innovative, multidisciplinary one with an eye to practical and policy implications.  Its mission is to add to the knowledge base needed to better understand the aging process and the societal implications of our increased potential for living longer lives. For more information about this center which is based at the Columbia Mailman School of Public Health, please visit: aging.columbia.edu.

Columbia University Mailman School of Public Health

Founded in 1922, the Columbia University Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Columbia Mailman School is the third largest recipient of NIH grants among schools of public health. Its nearly 300 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change and health, and public health preparedness. It is a leader in public health education with more than 1,300 graduate students from 55 nations pursuing a variety of master’s and doctoral degree programs. The Columbia Mailman School is also home to numerous world-renowned research centers, including ICAP and the Center for Infection and Immunity. For more information, please visit www.mailman.columbia.edu.

 

 

 

Unpacking the bias of large language models


In a new study, researchers discover the root cause of a type of bias in LLMs, paving the way for more accurate and reliable AI systems



Massachusetts Institute of Technology





Cambridge, MA – Research has shown that large language models (LLMs) tend to overemphasize information at the beginning and end of a document or conversation, while neglecting the middle.

This “position bias” means that, if a lawyer is using an LLM-powered virtual assistant to retrieve a certain phrase in a 30-page affidavit, the LLM is more likely to find the right text if it is on the initial or final pages.

MIT researchers have discovered the mechanism behind this phenomenon.

They created a theoretical framework to study how information flows through the machine-learning architecture that forms the backbone of LLMs. They found that certain design choices which control how the model processes input data can cause position bias.

Their experiments revealed that model architectures, particularly those affecting how information is spread across input words within the model, can give rise to or intensify position bias, and that training data also contribute to the problem.

In addition to pinpointing the origins of position bias, their framework can be used to diagnose and correct it in future model designs.

This could lead to more reliable chatbots that stay on topic during long conversations, medical AI systems that reason more fairly when handling a trove of patient data, and code assistants that pay closer attention to all parts of a program.

“These models are black boxes, so as an LLM user, you probably don’t know that position bias can cause your model to be inconsistent. You just feed it your documents in whatever order you want and expect it to work. But by understanding the underlying mechanism of these black-box models better, we can improve them by addressing these limitations,” says Xinyi Wu, a graduate student in the MIT Institute for Data, Systems, and Society (IDSS) and the Laboratory for Information and Decision Systems (LIDS), and first author of a paper on this research.

Her co-authors include Yifei Wang, an MIT postdoc; and senior authors Stefanie Jegelka, an associate professor of electrical engineering and computer science (EECS) and a member of IDSS and the Computer Science and Artificial Intelligence Laboratory (CSAIL); and Ali Jadbabaie, professor and head of the Department of Civil and Environmental Engineering, a core faculty member of IDSS, and a principal investigator in LIDS. The research will be presented at the International Conference on Machine Learning.

 

Analyzing attention

LLMs like Claude, Llama, and GPT-4 are powered by a type of neural network architecture known as a transformer. Transformers are designed to process sequential data, encoding a sentence into chunks called tokens and then learning the relationships between tokens to predict what words comes next.

These models have gotten very good at this because of the attention mechanism, which uses interconnected layers of data processing nodes to make sense of context by allowing tokens to selectively focus on, or attend to, related tokens.

But if every token can attend to every other token in a 30-page document, that quickly becomes computationally intractable. So, when engineers build transformer models, they often employ attention masking techniques which limit the words a token can attend to.

For instance, a causal mask only allows words to attend to those that came before it.

Engineers also use positional encodings to help the model understand the location of each word in a sentence, improving performance.

The MIT researchers built a graph-based theoretical framework to explore how these modeling choices, attention masks and positional encodings, could affect position bias.

“Everything is coupled and tangled within the attention mechanism, so it is very hard to study. Graphs are a flexible language to describe the dependent relationship among words within the attention mechanism and trace them across multiple layers,” Wu says.

Their theoretical analysis suggested that causal masking gives the model an inherent bias toward the beginning of an input, even when that bias doesn’t exist in the data.

If the earlier words are relatively unimportant for a sentence’s meaning, causal masking can cause the transformer to pay more attention to its beginning anyway.

“While it is often true that earlier words and later words in a sentence are more important, if an LLM is used on a task that is not natural language generation, like ranking or information retrieval, these biases can be extremely harmful,” Wu says.

As a model grows, with additional layers of attention mechanism, this bias is amplified because earlier parts of the input are used more frequently in the model’s reasoning process.

They also found that using positional encodings to link words more strongly to nearby words can mitigate position bias. The technique refocuses the model’s attention in the right place, but its effect can be diluted in models with more attention layers.

And these design choices are only one cause of position bias — some can come from training data the model uses to learn how to prioritize words in a sequence.

“If you know your data are biased in a certain way, then you should also finetune your model on top of adjusting your modeling choices,” Wu says.

 

Lost in the middle

After they’d established a theoretical framework, the researchers performed experiments in which they systematically varied the position of the correct answer in text sequences for an information retrieval task.

The experiments showed a “lost-in-the-middle” phenomenon, where retrieval accuracy followed a U-shaped pattern. Models performed best if the right answer was located at the beginning of the sequence. Performance declined the closer it got to the middle before rebounding a bit if the correct answer was near the end.

Ultimately, their work suggests that using a different masking technique, removing extra layers from the attention mechanism, or strategically employing positional encodings could reduce position bias and improve a model’s accuracy.

“By doing a combination of theory and experiments, we were able to look at the consequences of model design choices that weren’t clear at the time. If you want to use a model in high-stakes applications, you must know when it will work, when it won’t, and why,” Jadbabaie says.

In the future, the researchers want to further explore the effects of positional encodings and study how position bias could be strategically exploited in certain applications.

###

This research is supported, in part, by the U.S. Office of Naval Research, the National Science Foundation, and an Alexander von Humboldt Professorship.

 

Recreating an important moment on the evolutionary timescale




Michigan State University
Cyanobacteria 

image: 

Cyanobacteria is a photosynethetic organism, and by living inside a single-cell organism billions of years ago, it lead to the evolution of the chloroplast. 

view more 

Credit: Kara Headley





Plants have been making their own food for millions of years through photosynthesis. Photosynthesis takes place within an organelle of plants and algae known as the chloroplast, which is a vital piece of cellular machinery that has made life on Earth as we know it possible.

Evidence has shown that the chloroplast evolved 2.1 billion years ago through endosymbiosis, wherein one organism lives inside another. A single-celled organism engulfed cyanobacteria, a photosynthetic bacteria. Having one organism living within another creates a working relationship known as endosymbiosis. From there, evolutionary processes that are largely unknown converted the free-living cyanobacterium into the modern chloroplast we see in plants and algae.

A new project aims to recreate the engulfment of cyanobacteria, to gain insight into the process and to how this partnership is maintained. This research is important to understanding a new frontier of bioengineering. If researchers can better understand why these organisms work well together, the knowledge could be applied to other areas of bioengineering, like the creation of sustainable biofuels.

This project is an international collaboration between three researchers with differing expertise: Daniel Ducat from the Michigan State University-Department of Energy Plant Research Laboratory, or PRL, Johan Decelle from the French National Centre for Scientific Research and Dietrich Kohlheyer from the Jülich Research Center.

“We have to be a little bit generous in our interpretation, because obviously we're not able to take a time machine back,” said Ducat, a professor in the PRL and the Department of Biochemistry and Molecular Biology. “A fundamental question is: What kinds of processes or what kinds of partners were the best suited for one another that could have given rise to the chloroplast over time?”

In order to accomplish this, the team is turning to Paramecium bursaria, a relatively obscure single-celled organism that can engulf algae and cyanobacteria. The researchers are investigating what happens when engineered cyanobacterial strains are introduced into bursaria – mainly, how they survive and contribute to the fitness of their new host over time.

The team is not trying to recreate the chloroplast; instead, they are looking at key features or environmental conditions that might be necessary to make cyanobacteria go from a temporary renter to a full-time resident in the condominium that is bursaria.

The second question of the project is one of synthetic biology and engineering. Bursaria is already primed to take in a renter, but what makes it able to do so? The researchers will explore how other organisms might become landlords to their own symbionts.

Researchers are also interested in creating engineered communities of microorganisms. This involves bringing multiple microbial species together that each have specializations, but which cooperate towards a common goal. The research may also answer long-held questions about the nature of endosymbiosis.

The project brings together three labs from different countries, each with compatible but distinct areas of expertise. Johan Decelle has expertise in the organism Paramecium bursaria and advanced visualization techniques. Dietrich Kohlheyer has expertise in microfluidic devices. Daniel Ducat is the cyanobacteria expert on the project.

“My experience of science is that the best projects are ones that are done at the interface,” Ducat said. “We often get in our own silos where we're pursuing our individual research projects. But often when you have more than one group coming together with different expertise, they are each bringing their own perspective and talents in a way that's going to build something much greater than the sum of its parts.”

Paramecium bursaria in endosymbiosis with microalgae, as seen under a microscope. 

Credit

Science Photo Library

 

Food insecurity, neighborhood, lack of social support, linked to worse stroke recovery




Despite these challenges, the same factors were linked to higher survival rates



American Academy of Neurology



 

Highlights:

  • Having at least one social factor affecting health, like food insecurity or not having a safe place to live or enough social support, was linked to worse recovery after stroke.

  • Food insecurity, the most common factor, was linked to having trouble moving, needing a breathing or feeding tube or hospice care.

  • Even though they had worse recovery rates, people with these factors had better survival rates up to one year after stroke compared to those without negative social factors.

  • This unexpected finding suggests worse recovery does not necessarily translate to poorer survival, and more research is needed to determine why.

MINNEAPOLIS — Having poor access to food, living in a disadvantaged neighborhood and not having strong friend and family support may lead to worse outcomes after stroke, according to a study published June 18, 2025, in Neurology® Clinical Practice, an official journal of the American Academy of Neurology. Conversely, the study found that people with these negative social factors had better survival rates after stroke. The study does not prove that socioeconomic factors lead to worse outcomes and better survival from stroke; it only shows an association.

The study looked at people with intracerebral hemorrhage, which is caused by bleeding in the brain.

“A growing body of research suggests that social determinants of health, non-medical factors such as socioeconomic status, employment, social support networks and health care access play a crucial role in how people develop, recover and survive various health conditions,” said study author Fady T. Charbel, MD, of University of Illinois Chicago. “Our study found certain social disparities negatively impacted recovery after a bleeding stroke, yet surprisingly, these same factors were tied to a higher rate of survival, which reflects the complex connection between social factors and health outcomes.”

The study involved 481,754 people.

U.S. Census data and participants’ addresses were used to collect information on social factors such as food insecurity and neighborhood indicators such as access to safe housing, environmental quality and access to transportation and recreational spaces. Researchers also looked at civic participation and social and support networks.

The 240,877 people who had experienced at least one negative social factor were compared to 240,877 people who had no history of negative social factors. Of the group with negative social factors, 87% experienced food insecurity, 14% experienced a social disparity, and 8% experienced a neighborhood disparity. Food insecurity is not having enough food or enough affordable, nutritious food.

Researchers found food insecurity was associated with a 61% increased risk of movement problems, a 98% increased risk of having a feeding tube, double the risk of needing a breathing tube, and a 35% increased risk of hospice care.

Researchers looked at recovery within 30 days of stroke and survival rates at 90 days and one year after the stroke.

People who experienced at least one negative social factor were more likely to have worse outcomes than those who had not. They had a 2% rate of needing a breathing tube compared to 0.9%. They had a 3.2% rate for both needing a feeding tube or a wheelchair, compared to 1.5% and 2.5%, respectively, for those who did not experience negative social factors. They also had a higher rate of being readmitted to the hospital at 9.8% compared to 6.2%.

Conversely, researchers found those who experienced negative social factors actually had better survival rates when compared to those who had not experienced negative social factors. Three months after stroke, their survival rate was 78% compared to 73%. One year after stroke, they had a survival rate of 62% compared to 58%.

“One possible explanation for this unexpected finding is that people who experience social disparities were more likely to use life-sustaining interventions such as feeding and breathing tubes,” said Charbel. “Another potential factor is disparities in access to palliative care services. Our study highlights the need to address the root causes of these disparities such as poverty and inadequate health care in order to develop better care for people after they have a stroke.”

A limitation of the study was that researchers were unable to gather racial or ethnic information, so the findings may be different for specific groups.

Discover more about stroke at BrainandLife.org, from the American Academy of Neurology. This resource also offers a magazine, podcast, and books that connect patients, caregivers and anyone interested in brain health with the most trusted information, straight from the world’s leading experts in brain health. Follow Brain & Life® on FacebookX, and Instagram.

The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 40,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on FacebookXInstagramLinkedIn, and YouTube.

 

Two-part vaccine strategy generates a stronger, longer-lasting immune boost against HIV



Scripps Research scientists’ new approach combines two immune-activating molecules known as adjuvants



Scripps Research Institute





LA JOLLA, CA—In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They found that a two-part delivery strategy can train the immune system to produce a stronger response to HIV, offering new hope in the fight against one of the world’s most elusive viruses.

The approach, described in Science Translational Medicine on June 18, 2025, used a mouse model to test two types of adjuvants: immune-boosting molecules that improve vaccine response. One of the adjuvants helped the HIV protein persist longer in the body, and another amplified immune activation. When combined, the adjuvants led to stronger and more potent antibody responses than either one alone.

“Using a dual-adjuvant strategy pulls together the best of both worlds,” says senior author Darrell Irvine, a professor of immunology and microbiology at Scripps Research.

Vaccines work by teaching the body to recognize dangerous viruses and bacteria, but HIV has proven to be a particularly challenging target because it mutates rapidly and hides from immune defenses. To explore how to tackle this issue, the research team used an experimental HIV protein called MD39—a type of antigen, or molecule that triggers an immune reaction.

MD39 was designed in a lab to resemble the virus’s outer envelope. It’s structured to guide the immune system toward generating broadly neutralizing antibodies (bnAbs): rare immune proteins that can recognize and block a wide range of HIV variants.

The antigen was paired with three different adjuvant strategies to test which elicited the strongest immune response. One approach used a formulation where MD39 was tagged with phosphoserine (pSer), allowing the protein to anchor to particles of aluminum hydroxide (alum)—a widely used adjuvant that enhances immune activity. This formulation enables slow release, prolonging the protein’s presence in the body and giving immune cells more time to recognize and react to it.

A second strategy employed saponin/MPLA nanoparticles (SMNP). This adjuvant contains saponins, natural compounds found in plants that stimulate the immune system. To ramp up the immune response, SMNP delivers vaccine components to key immune sites, such as lymph node follicles—regions where immune “training” happens. These follicles are rich in B cells: white blood cells that, when mature, can produce high-quality antibodies like bnAbs.

The third and final method—which incorporated both alum-pSer and SMNP—yielded the best outcomes.

“The idea to combine the adjuvants actually came from studying them separately,” notes Irvine. “The classic adjuvant alum is well known, very safe, but not as potent an adjuvant, whereas SMNP really drives robust activation of the immune system, so it seemed reasonable to explore whether putting the two together would be much more effective.”

Results of the dual-adjuvant strategy were striking: B cells multiplied, matured more quickly and became increasingly diverse—a critical factor for generating antibodies that can fight multiple variants of HIV. Notably, MD39 remained detectable in lymph nodes for up to four weeks, allowing the protein to accumulate in follicles.

“The intact antigen buildup contributed to the significant effects we observed,” says co–first author Yiming “Jason” Zhang, a postdoctoral scientist at the Massachusetts Institute of Technology (MIT), where Irvine previously led his lab. “This suggests other techniques that achieve this kind of follicular buildup could also result in a strong immune response.”

The researchers compared their results to previous data from non-human primates that had received the same protein and adjuvants. Encouragingly, the combination approach led to similarly strong and diverse immune responses.

While the full, two-part vaccine strategy hasn’t been tested yet in humans, the SMNP adjuvant is currently under evaluation in a first-in-human clinical trial (HVTN 144).

“Its safety profile will probably be comparable to Shingrix, which is a shingles vaccine that has a very potent adjuvant like SMNP,” says Irvine. “You might get some pain in your arm or flu-like symptoms for a day or so, but nothing much worse than that.”

In addition to Irvine and Zhang, authors of the study, “Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion,” are Kristen A. Rodrigues, Aereas Aung, Anna Romanov, Laura Maiorino, Parisa Yousefpour, Grace Gibson, Gabriel Ozorowski, Justin R. Gregory, Parastoo Amlashi, Maureen Buckley, Andrew B. Ward and William R. Schief of Scripps Research; and Jonathan Lam, Duncan M. Morgan, Richard Van and J. Christopher Love of MIT.

This work was supported by funding from the National Institutes of Health (grants P30-CA14051 (Koch Institute Core grant), UM1AI144462, AI161818, AI161297, AI125068 and P01AI048240); the National Institutes of Health Fellowship F32 AI164829; the Ragon Institute of Mass General Brigham, MIT, and Harvard; MIT; Harvard; and the Howard Hughes Medical Institute.

About Scripps Research

Scripps Research is an independent, nonprofit biomedical research institute ranked one of the most influential in the world for its impact on innovation by Nature Index. We are advancing human health through profound discoveries that address pressing medical concerns around the globe. Our drug discovery and development division, Calibr-Skaggs, works hand-in-hand with scientists across disciplines to bring new medicines to patients as quickly and efficiently as possible, while teams at Scripps Research Translational Institute harness genomics, digital medicine and cutting-edge informatics to understand individual health and render more effective healthcare. Scripps Research also trains the next generation of leading scientists at our Skaggs Graduate School, consistently named among the top 10 US programs for chemistry and biological sciences. Learn more at www.scripps.edu.